أعرض في EDS

CO73 Amivantamab Versus Real-World Clinical Practice in Europe and the US for Patients With Advanced Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations

التفاصيل البيبلوغرافية
العنوان:	CO73 Amivantamab Versus Real-World Clinical Practice in Europe and the US for Patients With Advanced Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations
المؤلفون:	C Chouaid, N Girard, A Kron, M Scheffler, C Knott, L Bosquet, J Trigo, S Viteri, M Sebastian, S Popat, N Rahhali, R Toueg, B Rodrigues, J Diels, CA Schioppa, J Cabrieto, J Sermon, NJ Perualila, N Erdmann, J Mielke, M Nematian-Samani, I Pfaira, C Martin-Fernandez, P Mahadevia, T Li, C Pick-Lauer, A Adamczyk, J Penton, J Wolf
المصدر:	Value in Health. 25:S32
بيانات النشر:	Elsevier BV, 2022.
سنة النشر:	2022
مصطلحات موضوعية:	Health Policy, Public Health, Environmental and Occupational Health
تدمد:	1098-3015
URL الوصول:	https://explore.openaire.eu/search/publication?articleId=doi_________::b96eebb8bd08ca951e7758986743303e https://doi.org/10.1016/j.jval.2022.09.152
حقوق:	CLOSED
رقم الأكسشن:	edsair.doi...........b96eebb8bd08ca951e7758986743303e
قاعدة البيانات:	OpenAIRE

الوصف
تدمد:	10983015